• Redx Annual Results December 2023

    Read more
  • Admission of Subscription Shares and TVR

    Read more
  • Results of General Meeting

    Read more
  • Redx Unveils Preclinical Data from RXC009

    Read more
  • Redx to present preclinical data on RXC009 at ASN

    Read more
  • Redx Presenting at AFDD Meeting

    Read more
  • Redx to Present RXC004 Phase 1 Combination Data

    Read more
  • Redx to Present Poster at ASN Kidney Week

    Read more
  • RXC004 Phase 1 monotherapy data to be presented at ESMO Congress 2021

    Read more
  • Interim results for the six months ended 31 March

    Read more